Erlotib 100 mg Tablet

About Erlotib 100 mg Tablet

Erlotib 100 mg tablets are a targeted therapy designed to combat specific forms of cancer, particularly non-small cell lung cancer (NSCLC) and pancreatic cancer. This medication functions by inhibiting the action of epidermal growth factor receptor (EGFR) tyrosine kinase, a crucial protein that promotes cancer cell growth and division. By blocking this pathway, Erlotib helps to slow down the progression of tumors and can lead to improved patient outcomes. Its essential for patients to discuss their complete medical history with their healthcare provider before starting treatment, as Erlotib may not be suitable for everyone and can cause side effects, including skin rash and diarrhea. Regular monitoring and follow-up appointments are vital to manage any potential adverse reactions effectively. As with any cancer treatment, adherence to the prescribed regimen and timely communication with healthcare professionals can significantly influence the effectiveness of Erlotib. If you or a loved one are considering this medication, consult with an oncologist to understand its role in your treatment plan.